Disease & disorder
renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
MONDO:0006397
A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns.
Outbreak surveillance
Global reported eventsExplore recent public health notices potentially related to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. Results are keyword matches, not yet verified disease-to-outbreak relationships.
View renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions on the outbreak map →Advertisement
Background context
renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.